Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) EBT (2016 - 2025)

Historic EBT for STRATA Skin Sciences (SSKN) over the last 13 years, with Q3 2025 value amounting to -$1.6 million.

  • STRATA Skin Sciences' EBT rose 2179.36% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.3 million, marking a year-over-year decrease of 949.37%. This contributed to the annual value of -$10.3 million for FY2024, which is 609.78% up from last year.
  • STRATA Skin Sciences' EBT amounted to -$1.6 million in Q3 2025, which was up 2179.36% from -$2.5 million recorded in Q2 2025.
  • In the past 5 years, STRATA Skin Sciences' EBT registered a high of $1.1 million during Q2 2021, and its lowest value of -$4.7 million during Q4 2024.
  • For the 5-year period, STRATA Skin Sciences' EBT averaged around -$1.9 million, with its median value being -$2.1 million (2024).
  • As far as peak fluctuations go, STRATA Skin Sciences' EBT surged by 16650.34% in 2021, and later tumbled by 390618.56% in 2023.
  • STRATA Skin Sciences' EBT (Quarter) stood at -$827000.0 in 2021, then surged by 88.27% to -$97000.0 in 2022, then tumbled by 3906.19% to -$3.9 million in 2023, then fell by 21.59% to -$4.7 million in 2024, then soared by 65.67% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$2.5 million for Q2 2025, and -$2.4 million during Q1 2025.